48 results
6-K
EX-1.1
SCNI
Scinai Immunotherapeutics Ltd
19 Sep 23
Report of Foreign Private Issuer
3:06pm
fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock
10-K
2022 FY
SCNI
Scinai Immunotherapeutics Ltd
17 Apr 23
Annual report
4:06pm
business.
Coverage and Reimbursement
Sales of any pharmaceutical product depend, in part, on the extent to which such product will be covered by third … , and the level of reimbursement for such product by third-party payors. Decisions regarding the extent of coverage and amount of reimbursement to be provided
6-K
EX-1.1
SCNI
Scinai Immunotherapeutics Ltd
20 Dec 22
BiondVax Announces Closing of $8 Million Underwritten Public Offering
5:29pm
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits
424B4
SCNI
Scinai Immunotherapeutics Ltd
20 Dec 22
Prospectus supplement with pricing info
11:59am
, Pre-funded Warrants only, Warrants only, or any combination thereof.
Discounts, Commissions and Reimbursement
The underwriter has advised us
F-1/A
EX-1.1
SCNI
Scinai Immunotherapeutics Ltd
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option
F-1/A
gm5d13xav3e2ivk2ncw
12 Dec 22
Registration statement (foreign) (amended)
5:25pm
6-K
EX-99.1
n7d8yf axlgb
10 Nov 22
Current Report
5:28pm
F-1
8aib wvy49gz
29 Sep 22
Registration statement (foreign)
9:22am
6-K
EX-1.1
1nfxe60z22t qens
29 Dec 21
Report of Foreign Private Issuer
6:06am
424B5
khvn4z 3xuj
28 Dec 21
Prospectus supplement for primary offering
5:20pm
424B5
tm4lh9 1qh
27 Dec 21
Prospectus supplement for primary offering
6:22am
6-K
EX-99.1
cgfi2v0 d4dpe
22 Nov 21
Report of Foreign Private Issuer
6:05am
6-K
EX-99.1
xh86 d954u2eip
4 Mar 21
Report of Foreign Private Issuer
1:01pm
6-K
EX-1.1
1dk ezzjprsozpy
2 Feb 21
Report of Foreign Private Issuer
12:00am
424B5
dlrdy8
1 Feb 21
Prospectus supplement for primary offering
5:08pm